Zepbound

Healthcare

Merck Cautiously Enters GLP-1 Fray Via Licensing Deal With Chinese Drugmaker

Photo by Coolcaesar via CC BY-SA 4.0

By licensing a drug from Hansoh, Merck signaled that it isn’t prepared to fully challenge its rivals’ dominance in the GLP-1 space.

2 min read

Photo by Jetcityimage via iStock

Healthcare

Eli Lilly’s Weight-Loss Drug Finally Off FDA Shortage List

The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.

1 min read
Photo by Chemist4U via CC BY-SA 2.0

Healthcare

Making Weight-Loss Drugs Takes a Whole Lot of Muscle

In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.

1 min read

Photo illustration by Connor Lin / The Daily Upside, Photos by Vlad Yushinov and Choness via iStock

Consumer

Is the Restaurant Industry at the End of an Era?

Across-the-board inflation — including food costs, labor costs, and real estate costs — is pummeling restaurants. Can the industry survive?

6 min read
Photo by Nandaro via CC BY-SA 3.0

Media & Entertainment

2024: The Year Legacy Media Gave Up on Cable

In 2024, legacy media giants like Disney and NBCUniversal finally had enough with cable — and started making their own off-ramps.

1 min read
Photo by Ajay Suresh via CC BY 2.0

Media & Entertainment

2024: The Year YouTube Became TV

YouTube may have started off as a platform for small screens, but now it’s increasingly dominating the living room TV.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.